Disulfide cross-linked phosphorylcholine micelles for triggered release of camptothecin

Molecular Pharmaceutics

Volumn 10, Issue 7, 2013, Pages 2684-2692

  McRae Page, Samantha ^a   Martorella, Molly ^a   Parelkar, Sangram ^a   Kosif, Irem ^a   Emrick, Todd ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

camptothecin; cancer drugs; drug delivery; poly(methacryloyloxyethyl phosphorylcholine); polymer micelle; polymer prodrug; polymer drug conjugate

Indexed keywords

2 METHACRYLOYLOXYETHYLPHOSPHORYLCHOLINE; ANTIINFECTIVE AGENT; CAMPTOTHECIN; COPOLYMER; DIHYDROLIPOATE; DISULFIDE; DITHIOTHREITOL; METHACRYLIC ACID; PHOSPHORYLCHOLINE; POLYMER; WATER;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG HALF LIFE; DRUG RELEASE; DYNAMIC LIGHT SCATTERING; FLUORESCENCE SPECTROSCOPY; HUMAN; HUMAN CELL; LIGHT SCATTERING; MICELLE; POLYMERIZATION; PRIORITY JOURNAL; SYNTHESIS;

CAMPTOTHECIN; CELL LINE, TUMOR; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MICELLES; MICROSCOPY, ELECTRON, TRANSMISSION; PHOSPHORYLCHOLINE; POLYMERS; PRODRUGS;

EID: 84879719728     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp400114n     Document Type: Article

References (47)

1. Duncan, R. Polymer conjugates as anticancer nanomedicines. Nat. Rev. Cancer 2006, 6, 688-701.
2. Pasut, G.; Veronese, F. M. PEG conjugates in clinical development or use as anticancer agents: An overview. Adv. Drug Delivery Rev. 2009, 61, 1177-1188.
3. Joralemon, M. J.; McRae, S.; Emrick, T. PEGylated polymers for medicine: from conjugation to self-assembled systems. Chem. Commun. 2010, 46, 1377-1393.
4. Maeda, H.; Wu, J.; Sawa, T.; Matsumura, Y.; Hori, K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J. Controlled Release 2000, 65, 271-284.
5. Greenwald, R. B.; Choe, Y. H.; McGuire, J.; Conover, C. D. Effective drug delivery by PEGylated drug conjugates. Adv. Drug Delivery Rev. 2003, 55, 217-250.
6. Thomson, A. H.; Vasey, P. A.; Murray, L. S.; Cassidy, J.; Fraier, D.; Frigerio, E.; Twelves, C. Population pharmacokinetics in phase I drug development: a phase I study of PK1 in patients with solid tumours. Br. J. Cancer 1999, 81, 99-107.
7. Seymour, L. W.; Ferry, D. R.; Kerr, D. J.; Rea, D.; Whitlock, M.; Poyner, R.; Boivin, C.; Hesslewood, S.; Twelves, C.; Blackie, R.; Schatzlein, A.; Jodrell, D.; Bissett, D.; Calvert, H.; Lind, M.; Robbins, A.; Burtles, S.; Duncan, R.; Cassidy, J. Phase II studies of polymerdoxorubicin (PK1, FCE 28068) in the treatment of breast, lung, and colorectal cancer. Int. J. Oncol. 2009, 34, 1629-1636.
8. Bissett, D.; Cassidy, J.; Bono, J. S.; Muirhead, F.; Main, M.; Robson, L.; Fraier, D.; Magne, M. L.; Pellizzoni, C.; Porro, M. G.; Spinelli, R.; Speed, W.; Twelves, C. Phase I and pharmacokinetic (PK) study of MAG-CPT (PNU 166148): a polymeric derivative of camptothecin (CPT). Br. J. Cancer 2004, 91, 50-55.
9. Kopecek, J.; Kopeckova, P.; Minko, T.; Lu, Z. HPMA copolymeranticancer drug conjugates: design, activity, and mechanism of action. Eur. J. Pharm. Biopharm. 2006, 50, 61-81.
10. Schluep, T.; Hwang, J.; Cheng, J. J.; Heidel, J. D.; Bartlett, D. W.; Hollister, B.; Davis, M. E. Preclinical efficacy of the camptothecinpolymer conjugate IT-101 in multiple cancer models. Clin. Cancer Res. 2006, 12, 1606-1614.
11. Numbenjapon, T.; Wang, J. Y.; Colcher, D.; Schluep, T.; Davis, M. E.; Duringer, J.; Kretzner, L.; Yen, Y.; Forman, S. J.; Raubitschek, A. Preclinical results of camptothecin- polymer conjugate (IT-101) in multiple human lymphoma xenograft models. Clin. Cancer Res. 2009, 15, 4365-4373.
12. Chen, X.; McRae, S.; Parelkar, S.; Emrick, T. Polymeric Phosphorylcholine- Camptothecin Conjugates Prepared by Controlled Free Radical Polymerization and Click Chemistry. Bioconjugate Chem. 2009, 20, 2331-2341.
13. Chen, X.; Parelkar, S.; Henchey, E.; Schneider, S.; Emrick, T. PolyMPC-Doxorubicin Prodrugs. Bioconjugate Chem. 2012, 23, 1753-1763.
14. Lee, C. C.; Gillies, E. R.; Fox, M. E.; Guillaudeu, S. J.; Fre?chet, J. M. J.; Dy, E. E.; Szoka, F. C. A single dose of doxorubicinfunctionalized bow-tie dendrimer cures mice bearing C-26 colon carcinomas. Proc. Natl. Acad. Sci. U.S.A. 2006, 103, 16649-16654.
15. Guillaudeu, S.; Fox, M.; Haidar, Y.; Dy, E.; Szoka, F.; Fre?chet, J. M. J. PEGylated dendrimers with core functionality for biological applications. Bioconjugate Chem. 2008, 19, 461-469.
16. Alakhov, V.; Klinski, E.; Li, S.; Pietrzynski, G.; Venne, A.; Batrakova, E. V.; Bronitch, T.; Kabanov, A. V. Block copolymer-based formulation of doxorubicin. From cell screen to clinical trials. Colloids Surf., B 1999, 16, 113-134.
17. Nakanishi, T.; Fukushima, S.; Okamoto, K.; Suzuki, M.; Matsumura, Y.; Yokoyama, M.; Okano, T.; Sakurai, Y.; Kataoka, K. Development of the polymer micelle carrier system for doxorubicin. J. Controlled Release 2001, 74, 295-302.
18. Christian, D. A.; Cai, S.; Garbuzenko, O. B.; Harada, T.; Zajac, A. L.; Minko, T.; Discher, D. E. Flexible Filaments for in Vivo Imaging and Delivery: Persistent Circulation of Filomicelles Opens the Dosage Window for Sustained Tumor Shrinkage. Mol. Pharmaceutics 2009, 6, 1343-1352.
19. van Nostrum, C. F. Covalently cross-linked amphiphilic block copolymer micelles. Soft Matter 2011, 7, 3246-3259.
20. Gohy, J.- F. Block Copolymer Micelles. Adv. Polym. Sci. 2005, 190, 65-136.
21. Jones, M.-C.; Leroux, J.-C. Polymeric micelles-a new generation of colloidal drug carriers. Eur. J. Pharm. Biopharm. 1999, 48, 101-111.
22. OReilly, R. K.; Hawker, C. J.; Wooley, K. L. Cross-linked block copolymer micelles: functional nanostructures of great potential and versatility. Chem. Soc. Rev. 2006, 35, 1068-1083.
23. Peer, D.; Karp, J. M.; Hong, S.; Farokhzad, O. C.; Margalit, R.; Langer, R. Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol. 2007, 2, 751-760.
24. Li, Y. T.; Lokitz, B. S.; McCormick, C. L. RAFT synthesis of a thermally responsive ABC triblock copolymer incorporating Nacryloxysuccinimide for facile in situ formation of shell cross-linked micelles in aqueous media. Macromolecules 2006, 39, 81-89.
25. Duong, H. T. T.; Nguyen, T. L. U.; Stenzel, M. H. Micelles with surface conjugated RGD peptide and crosslinked polyurea core via RAFT polymerization. Polym. Chem. 2010, 1, 171-182.
26. Iijima, M.; Nagasaki, Y.; Okada, T.; Kato, M.; Kataoka, K. Corepolymerized reactive micelles from heterotelechelic amphiphilic block copolymers. Macromolecules 1999, 32, 1140-1146.
27. Lee, W.-C.; Li, Y.-C.; Chu, I.-M. Amphiphilic poly(D,L-lactic acid)/poly(ethylene glycol)/poly(D,L-lactic acid) nanogels for controlled release of hydrophobic drugs. Macromol. Biosci. 2006, 6, 846-854.
28. Henselwood, F.; Liu, G. Water-soluble nanospheres of poly(2- cinnamoylethyl methacrylate)-block-poly(acrylic acid). Macromolecules 1997, 30, 488-493.
29. Saito, K.; Ingalls, L. R.; Lee, J.; Warner, J. C. Core-bound polymeric micellar system based on photocrosslinking of thymine. Chem. Commun. 2007, 24, 2503-2505.
30. Meng, F.; Hennink, W. E.; Zhong, Z. Reduction-sensitive polymers and bioconjugates for biomedical applications. Biomaterials 2009, 30, 2180-2198.
31. Cheng, R.; Feng, F.; Meng, F.; Deng, C.; Feijen, J.; Zhong, Z. Glutathione-responsive nano-vehicles as a promising platform for targeted intracellular drug and gene delivery. J. Controlled Release 2011, 152, 2-12.
32. Hu, X.; Li, H.; Luo, S.; Liu, T.; Jiang, Y.; Liu, S. Thiol and pH dual-responsive dynamic covalent shell cross-linked micelles for triggered release of chemotherapeutic drugs. Polym. Chem. 2013, 4, 695-706.
33. Convertine, A. J.; Diab, C.; Prieve, M.; Paschal, A.; Hoffman, A. S.; Johnson, P. H.; Stayton, P. S. pH-Responsive polymeric micelle carriers for siRNA drugs. Biomacromolecules 2010, 11, 2904-2911.
34. Schafer, F. Q.; Buettner, G. R. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radical Biol. 2011, 30, 1191-1212.
35. Kakizawa, Y.; Harada, A.; Kataoka, K. Environment-sensitive stabilization of core-chell structured polyion complex micelle by reverible cross-linking of the core through disulfide bond. J. Am. Chem. Soc. 1999, 121, 11247-11248.
36. Zhang, J.; Gong, M.; Yang, S.; Gong, Y.-K. Crosslinked biomimetic random copolymer micelles as potential anti-cancer drug delivery vehicle. J. Controlled Release 2011, 152, e1-e132.
37. Xu, Y.; Meng, F.; Cheng, R.; Zhong, Z. Reduction-sensitive reversible crosslinked biodgradable micelles for triggered release of doxorubicin. Macromol. Biosci. 2009, 9, 1254-1261.
38. Vetvicka, D.; Hruby, M.; Hovorka, O.; Etrych, T.; Vetrik, M.; Kovar, L.; Kovar, M.; Ulbrich, K.; Rihova, B. Biological evaluation of polymeric micelles with covalently bound doxorubicin. Bioconjugate Chem. 2009, 20, 2090-2097.
39. Cabral, H.; Nakanishi, M.; Kumagai, M.; Jang, W.-D.; Nishiyama, N.; Kataoka, K. A photo-activated targeting chemotherapy using glutathione sensitive camptothecin-loaded polymer micelles. Pharm. Res. 2009, 26, 82-92.
40. Konna, T.; Watanabe, J.; Ishihara, K. Enhanced solubility of paclitaxel using water- soluble and biocompatible 2-ethacryloyloxyethyl phosphorylcholine polymers. J. Biomed. Mater. Res., Part A 2002, 65, 209-214.
41. Chu, H.; Liu, N.; Wang, X.; Jiao, Z.; Chen, Z. Morphology and in vitro release kinetics of drug-loaded micelles based on well-defined PMPC-b-PBMA copolymer. Int. J. Pharm. 2009, 371, 190-196.
42. Wei, R.; Cheng, L.; Zheng, M.; Cheng, R.; Meng, F.; Deng, C.; Zhong, Z. Reduction- responsive disassemblable core-cross-linked micelles based on poly(ethylene glycol)-b- poly(N-2-hydroxypropyl methacrylamide)-lipoic acid conjugates for triggered intracellular anticancer drug release. Biomacromolecules 2012, 13, 2429-2438.
43. Ellman, G. L. Tissue Sulfhydryl groups. Arch. Biochem. Biophys. 1959, 82, 70-77.
44. Chen, X.; Lawrence, J.; Parelkar, S.; Emrick, T. Novel Zwitterionic Copolymers with Dihydrolipoic Acid: Synthesis and Preparation of Nonfouling Nanorods. Macromolecules 2012, 46, 119-127.
45. Digilio, G.; Menchise, V.; Gianolo, E.; Catanzaro, V.; Carrera, C.; Napolitano, R.; Fedeli, F.; Aime, S. Exofacial protein thiols as a route for the internalization of Gd(III)-based complexes for magnetic resonance imaging cell labeling. J. Med. Chem. 2010, 53, 4877-4890.
46. Davis, M. E.; Chen, Z.; Shin, D. M. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat. Rev. Drug Discovery 2008, 7, 771-782.
47. Duncan, R. The dawning era of polymer therapeutics. Nat. Rev. Drug Discovery 2003, 2, 347-360.